Amide proton transfer-weighted CEST MRI for radiotherapy target delineation of glioblastoma: a prospective pilot study

Autor: Patrick L. Y. Tang, Alejandra Méndez Romero, Remi A. Nout, Caroline van Rij, Cleo Slagter, Annemarie T. Swaak-Kragten, Marion Smits, Esther A. H. Warnert

Publikováno v: European Radiology Experimental, Vol 8, Iss 1, Pp 1-9 (2024)

Abstract Background Extensive glioblastoma infiltration justifies a 15-mm margin around the gross tumor volume (GTV) to define the radiotherapy clinical target volume (CTV). Amide proton transfer (APT)-weighted imaging could enable visualization of t

Externí odkaz: https://doaj.org/article/8ca38a2fcb0a4bdf95de0b48e77a133d

Intrafraction motion during partial breast irradiation depends on treatment time

Autor: Hoekstra, Nienke, Habraken, Steven, Swaak-Kragten, Annemarie, Hoogeman, Mischa, Pignol, Jean-Philippe

Publikováno v: In Radiotherapy and Oncology June 2021 159:176-182

Injection of radiopaque hydrogel at time of lumpectomy improves the target definition for adjuvant radiotherapy

Autor: Struik, Gerson M., Hoekstra, Nienke, Klem, Taco M., Ghandi, Ali, Verduijn, Gerda M., Swaak-Kragten, Annemarie T., Schoonbeek, Alja, de Vries, Kim C., Sattler, Margriet A., Verhoef, Kees, Birnie, Erwin, Pignol, Jean-Philippe

Publikováno v: In Radiotherapy and Oncology February 2019 131:8-13

Reducing the Risk of Secondary Lung Cancer in Treatment Planning of Accelerated Partial Breast Irradiation

Autor: Nienke Hoekstra, Steven Habraken, Annemarie Swaak-Kragten, Sebastiaan Breedveld, Jean-Philippe Pignol, Mischa Hoogeman

Publikováno v: Frontiers in Oncology, Vol 10 (2020)

Purpose: Adjuvant accelerated partial breast irradiation (APBI) results in low local recurrence risks. However, the survival benefit of adjuvant radiotherapy APBI for low-risk breast cancer might partially be offset by the risk of radiation-induced l

Externí odkaz: https://doaj.org/article/ab42cbfa44de4747bd2c32af1f019802

Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol

Autor: L. Bleeker, M. C. M. Kouwenhoven, I. de Heer, B. I. Lissenberg-Witte, A. H. Gijsbers, H. J. Dubbink, J. M. Kros, J. M. M. Gijtenbeek, E. Kurt, C. C. D. van der Rijt, A. T. Swaak-Kragten, F. Y. de Vos, H. L. van der Weide, P. J. French, M. J. van den Bent, P. Wesseling, J. E. C. Bromberg

Publikováno v: Journal of Neuro-Oncology, 162, 1, pp. 225-235
Journal of Neuro-Oncology, 162, 225-235
JOURNAL OF NEURO-ONCOLOGY, 162. SPRINGER
Journal of Neuro-Oncology, 162(1), 225-235. Kluwer Academic
Journal of Neuro-Oncology, 162(1), 225-235. Kluwer Academic Publishers
Bleeker, L, Kouwenhoven, M C M, de Heer, I, Lissenberg-Witte, B I, Gijsbers, A H, Dubbink, H J, Kros, J M, Gijtenbeek, J M M, Kurt, E, van der Rijt, C C D, Swaak-Kragten, A T, de Vos, F Y, van der Weide, H L, French, P J, van den Bent, M J, Wesseling, P & Bromberg, J E C 2023, ' Medulloblastoma in adults : evaluation of the Dutch society for neuro-oncology treatment protocol ', Journal of Neuro-Oncology, vol. 162, no. 1, pp. 225-235 . https://doi.org/10.1007/s11060-023-04285-8

Purpose Medulloblastoma is a rare tumor in adults. The objective of this nationwide, multicenter study was to evaluate the toxicity and efficacy of the Dutch treatment protocol for adult medulloblastoma patients. Methods Adult medulloblastoma patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67427e41dff228838387fb83cfe695a8